Literature DB >> 29268488

Extracapsular lymph node involvement in patients with esophageal cancer treated with neoadjuvant chemoradiation therapy followed by surgery: the closer you look, the less you see.

Yin-Kai Chao1.   

Abstract

Entities:  

Year:  2017        PMID： 29268488      PMCID： PMC5721006          DOI： 10.21037/jtd.2017.10.53

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  21 in total

Review 1.  Esophageal cancer.

Authors:  Peter C Enzinger; Robert J Mayer
Journal:  N Engl J Med       Date:  2003-12-04       Impact factor: 91.245

2.  Extracapsular lymph node involvement in node-positive patients with adenocarcinoma of the distal esophagus or gastroesophageal junction.

Authors:  Sjoerd M Lagarde; Fiebo J W ten Kate; Daan J de Boer; Olivier R C Busch; Hugo Obertop; J Jan B van Lanschot
Journal:  Am J Surg Pathol       Date:  2006-02       Impact factor: 6.394

Review 3.  A systematic review on the significance of extracapsular lymph node involvement in gastrointestinal malignancies.

Authors:  J Wind; S M Lagarde; F J W Ten Kate; D T Ubbink; W A Bemelman; J J B van Lanschot
Journal:  Eur J Surg Oncol       Date:  2006-12-15       Impact factor: 4.424

4.  Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy.

Authors:  Dylan R Nieman; Christian G Peyre; Thomas J Watson; Wenqing Cao; Michael D Lunt; Michal J Lada; Michelle S Han; Carolyn E Jones; Jeffrey H Peters
Journal:  Ann Thorac Surg       Date:  2014-11-05       Impact factor: 4.330

5.  Cancer of the esophagus and esophagogastric junction-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Authors:  Thomas W Rice; Donna M Gress; Deepa T Patil; Wayne L Hofstetter; David P Kelsen; Eugene H Blackstone
Journal:  CA Cancer J Clin       Date:  2017-05-26       Impact factor: 508.702

6.  Neoadjuvant chemoradiotherapy for esophageal cancer: impact on extracapsular lymph node involvement.

Authors:  Ralf Metzger; Elfriede Bollschweiler; Uta Drebber; Stefan P Mönig; Wolfgang Schröder; Hakan Alakus; Martin Kocher; Stephan E Baldus; Arnulf H Hölscher
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

7.  Tumor deposits in rectal adenocarcinoma after neoadjuvant chemoradiation are associated with poor prognosis.

Authors:  Purva Gopal; Pengcheng Lu; Gregory D Ayers; Alan J Herline; Mary K Washington
Journal:  Mod Pathol       Date:  2014-01-17       Impact factor: 7.842

8.  Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction.

Authors:  T Lerut; W Coosemans; G Decker; P De Leyn; N Ectors; S Fieuws; J Moons; P Nafteux; D Van Raemdonck
Journal:  J Thorac Cardiovasc Surg       Date:  2003-10       Impact factor: 5.209

9.  Prognostic impact of the extracapsular lymph node involvement on disease-free survival according to the 7th edition of American Joint Committee on Cancer Staging System.

Authors:  Thomas D'Annoville; Xavier Benoit D'Journo; Anderson Loundou; Delphine Trousse; Laetitia Dahan; Christophe Doddoli; Jean Francois Seitz; Pascal Alexandre Thomas
Journal:  Eur J Cardiothorac Surg       Date:  2013-06-30       Impact factor: 4.191

10.  Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction.

Authors:  Maarten C J Anderegg; Sjoerd M Lagarde; Vamshi P Jagadesham; Suzanne S Gisbertz; Arul Immanuel; Sybren L Meijer; Maarten C C M Hulshof; Jacques J G H M Bergman; Hanneke W M van Laarhoven; S Michael Griffin; Mark I van Berge Henegouwen
Journal:  Ann Surg       Date:  2016-11       Impact factor: 12.969
View more
  1 in total

1.  Extracapsular lymph node involvement after neoadjuvant chemoradiation in esophageal carcinoma: how to interpret?

Authors:  Lieven P Depypere; Philippe R Nafteux
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.